⌘K

Login Start Free

Home/Filings/4/0001008161-15-000008

4//SEC Filing

HEMISPHERX BIOPHARMA INC 4

Accession 0001008161-15-000008

$AIMCIK 0000946644operating

View on SEC.gov Company Profile

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 11:11 AM ET

Size

16.0 KB

Accession

0001008161-15-000008

Insider Transaction Report

Form 4

Period: 2015-12-09

HEMISPHERX BIOPHARMA INCHEB

CARTER WILLIAM A

DirectorCEO10% Owner

Transactions

Other
Options
2015-12-09−73,728→ 0 total
Exercise: $2.71From: 2010-12-22Exp: 2020-12-22→ Common Stock (73,728 underlying)
Other
Options
2015-12-09−150,000→ 0 total
Exercise: $0.25From: 2013-08-02Exp: 2023-08-02→ Common Stock (150,000 underlying)
Other
Options
2015-12-09−320,000→ 0 total
Exercise: $2.60From: 2015-12-08Exp: 2024-12-08→ Common Stock (320,000 underlying)
Other
Warrants
2015-12-09−491,196→ 0 total
Exercise: $0.51From: 2009-02-01Exp: 2019-02-01→ Common Stock (491,196 underlying)
Other
Options
2015-12-09−10,000→ 0 total
Exercise: $4.03From: 2012-04-13Exp: 2022-04-13→ Common Stock (10,000 underlying)
Other
Options
2015-12-09−100,000→ 0 total
Exercise: $0.29From: 2012-07-05Exp: 2022-06-06→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]As Section 5.1 in the 2009 Equity Incentive Plan states that there is an aggregate limitation of 3 million shares per person, these options and warrants were forfeited to comply with this limitation.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000946644

Filing Metadata

Form type: 4
Filed: Dec 13, 7:00 PM ET
Accepted: Dec 14, 11:11 AM ET
Size: 16.0 KB

View on SEC.gov